UCL Institute of Hepatology, UCL Faculty of Biomedical Sciences, University College London, London, UK.
Liver Int. 2011 Jan;31(1):99-107. doi: 10.1111/j.1478-3231.2010.02345.x. Epub 2010 Sep 16.
There is a need for better management strategies to improve the survival and quality of life in patients with biliary tract cancer (BTC).
To assess prognostic factors for survival in a large, non-selective cohort of patients with BTC.
We compared outcomes in 321 patients with a final diagnosis of BTC (cholangiocarcinoma n = 237, gallbladder cancer n = 84) seen in a tertiary referral cancer centre between 1998 and 2007. Survival according to disease stage and treatment category was compared using log-rank testing. Cox's regression analysis was used to determine independent prognostic factors.
Eighty-nine (28%) patients underwent a surgical intervention with curative intent, of whom 38% had R0 resections. Among the 321 patients, 34% were given chemo- and/or radiotherapy, 14% were palliated with photodynamic therapy (PDT) and 37% with biliary drainage procedures alone. The overall median survival was 9 months (3-year survival, 14%). R0-resective surgery conferred the most favourable outcome (3-year survival, 57%). Although patients palliated with PDT had more advanced clinical T-stages, their survival was similar to those treated with attempted curative surgery but who had positive resection margins. On multivariable analysis, treatment modality, serum carbohydrate-associated antigen 19-9, distant metastases and vascular involvement were independent prognostic indicators of survival.
In this large UK series of BTC, palliative PDT resulted in survival similar to those with curatively intended R1/R2 resections. Surgery conferred a survival advantage only in patients with R0 resection margins, emphasising the need for accurate pre-operative staging.
需要更好的管理策略来提高胆道癌(BTC)患者的生存率和生活质量。
评估大型非选择性 BTC 患者生存的预后因素。
我们比较了 1998 年至 2007 年间在一家三级转诊癌症中心确诊为 BTC(胆管癌 n = 237,胆囊癌 n = 84)的 321 例患者的结局。使用对数秩检验比较疾病分期和治疗类别的生存情况。使用 Cox 回归分析确定独立的预后因素。
89 例(28%)患者接受了根治性手术治疗,其中 38%为 R0 切除。在 321 例患者中,34%接受了化疗和/或放疗,14%接受了光动力疗法(PDT)姑息治疗,37%仅接受了胆道引流术。总体中位生存期为 9 个月(3 年生存率为 14%)。R0 切除手术带来了最有利的结果(3 年生存率为 57%)。尽管接受 PDT 姑息治疗的患者临床 T 分期较晚,但他们的生存情况与接受尝试根治性手术但切缘阳性的患者相似。多变量分析显示,治疗方式、血清碳水化合物相关抗原 19-9、远处转移和血管侵犯是生存的独立预后因素。
在这项英国 BTC 的大型系列研究中,姑息性 PDT 的生存效果与 R1/R2 根治性切除相似。手术仅在 R0 切缘患者中带来生存优势,强调了术前准确分期的必要性。